1. Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. Issue 6 (14th March 2020) Authors: Herishanu, Yair; Shaulov, Adir; Fineman, Riva; Bašić‐Kinda, Sandra; Aviv, Ariel; Wasik‐Szczepanek, Ewa; Jaksic, Ozren; Zdrenghea, Mihnea; Greenbaum, Uri; Mandac, Inga; Simkovic, Martin; Morawska, Marta; Benjamini, Ohad; Spacek, Martin; Nemets, Anatoly; Bairey, Osnat; Trentin, Livio; Ruchlemer, Ro... Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†. Issue 3 (23rd February 2019) Authors: Obr, Aleš; Prochazka, Vit; Papajik, Tomas; Klener, Pavel; Janikova, Andrea; Salek, David; Belada, David; Pytlík, Robert; Sykorova, Alice; Mocikova, Heidi; Simkovic, Martin; Campr, Vit; Dlouha, Jitka; Furst, Tomas; Trněný, Marek Journal: Leukemia & lymphoma Issue: Volume 60:Issue 3(2019) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance. Issue 5 (13th September 2018) Authors: Klener, Pavel; Fronkova, Eva; Kalinova, Marketa; Belada, David; Forsterova, Kristina; Pytlik, Robert; Blahovcova, Petra; Simkovic, Martin; Salek, David; Mocikova, Heidi; Prochazka, Vit; Janikova, Andrea; Vaskova, Martina; Mejstrikova, Ester; Kodet, Roman; Trka, Jan; Trneny, Marek Journal: Hematological oncology Issue: Volume 36:Issue 5(2018) Page Start: 773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial. Issue 1 (January 2019) Authors: Moreno, Carol; Greil, Richard; Demirkan, Fatih; Tedeschi, Alessandra; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Samoilova, Olga; Novak, Jan; Ben-Yehuda, Dina; Strugov, Vladimir; Gill, Devinder; Gribben, John G; Hsu, Emily; Lih, Chih-Jian; Zhou, Cathy; Clow, Fong; James, Danelle F; Styles, ... Journal: Lancet oncology Issue: Volume 20:Issue 1(2019) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma. Issue 1 (30th October 2017) Authors: Klener, Pavel; Fronkova, Eva; Belada, David; Forsterova, Kristina; Pytlik, Robert; Kalinova, Marketa; Simkovic, Martin; Salek, David; Mocikova, Heidi; Prochazka, Vit; Blahovcova, Petra; Janikova, Andrea; Markova, Jana; Obr, Ales; Berkova, Adela; Kubinyi, Jozef; Vaskova, Martina; Mejstrikova, Este... Journal: Hematological oncology Issue: Volume 36:Issue 1(2018) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗